Prosecution Insights
Last updated: August 06, 2026

Gemini Law LLP

10 pending office actions • 3 clients • 6 examiners • 5 art units • 0 of 10 (0%) have an AI response strategy ready

Quality Metrics (n=95 apps, methodology: how we score firms)

94.0%
Allowance Rate
n=95
+0.76σ
Allowance Rate (norm)
n=95
4.2
OAs to Allowance
n=63
+0.17σ
OAs to Allow (norm)
n=63
1059 days
Time to Allowance
n=63
+8.5pp
Interview Lift
n=95
52.2%
RCE Rate
n=95
1.4%
Appeal Rate
n=95

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=4 (min 20)
73.2%
§102 Overcome
n=41
75.8%
§103 Overcome
n=62
75.6%
§112 Overcome
n=41

Specialization & Scale

C08G, C09J, B32B
Top CPC Subclasses
62%
Top-3 CPC Share
n=95
5
Practitioners
n=95
19.0
Apps / Practitioner
n=95

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (30%)
6
Medium (60%)
1
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (50%)
§102 only1 (10%)
§112 only1 (10%)
Multi-statute (no §101)3 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
90% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
10% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RICE, STEVEN 3 38.3% +42.8%
LEONARD, MICHAEL L 2 63.7% +8.2%
HIBBERT, CATHERINE S 2 59.4% +47.9%
LOUNTOS, GEORGE THEMISTOCLIS 1 33.3% +0.0%
LEE, DORIS L 1 58.6% +8.6%
LI, AIQUN 1 64.0% +22.3%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18467967 Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells HIBBERT, CATHERINE S 9d overdue
17997679 SOLVENT-BASED LAMINATING ADHESIVE RICE, STEVEN 69d
19230980 Retort Adhesive Composition LEONARD, MICHAEL L

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18251446 Adhesive Composition RICE, STEVEN 66d overdue
18313946 COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF HIBBERT, CATHERINE S 31d overdue
18467967 Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells HIBBERT, CATHERINE S 9d overdue
17296238 ADHESIVE COMPOSITION LI, AIQUN 2d overdue
17997681 SOLVENT-BASED LAMINATING ADHESIVE RICE, STEVEN 69d
17997679 SOLVENT-BASED LAMINATING ADHESIVE RICE, STEVEN 69d

Client Portfolio (3 clients)

Client (Assignee)Pending OAs
Arkema 7
ToolGen 2
Richter Gedeon Nyrt. 1

Top Art Units

Art UnitApps
17873
17632
16582
17641
17661

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19230980 Retort Adhesive Composition Arkema France LEONARD, MICHAEL L 1763 §102§103Other Non-Final OA Pending Jun 06, 2025
18890829 METHOD FOR THE MANUFACTURE OF BIOPHARMACEUTICALS Richter Gedeon Nyrt. LOUNTOS, GEORGE THEMISTOCLIS §103 Non-Final OA Pending Sep 20, 2024
18286917 Two-Pack Polyurethane Composition Arkema France LEONARD, MICHAEL L 1763 §103 Non-Final OA 21d Pending Oct 13, 2023
18467967 Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells Toolgen Incorporated HIBBERT, CATHERINE S 1658 §103§112Other Non-Final OA 9d overdue Pending Sep 15, 2023
18313946 COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF Toolgen Incorporated HIBBERT, CATHERINE S 1658 §112Other Non-Final OA 31d overdue Pending May 08, 2023
18251446 Adhesive Composition Arkema France RICE, STEVEN 1787 §103 Final Rejection 66d overdue Pending May 02, 2023
17997681 SOLVENT-BASED LAMINATING ADHESIVE Arkema France RICE, STEVEN 1787 §103 Non-Final OA 69d Pending Nov 01, 2022
17997679 SOLVENT-BASED LAMINATING ADHESIVE Arkema France RICE, STEVEN 1787 §102§103 Final Rejection 69d Pending Nov 01, 2022
17997685 COMPOSITION HAVING POLYOL AND ISOCYANATE Arkema France LEE, DORIS L 1764 §102 Final Rejection 38d overdue Pending Nov 01, 2022
17296238 ADHESIVE COMPOSITION Arkema France LI, AIQUN 1766 §103 Non-Final OA 2d overdue Pending Aug 04, 2022

Managing Gemini Law LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month